MAX Chat
Company Analysis Baxter International
1. Summary
Advantages
- Dividends (3.19%) are higher than the sector average (1.3%).
- The company's current efficiency (ROE=-8.45%) is higher than the sector average (ROE=-73.65%)
Disadvantages
- Price (23.98 $) is higher than fair price (13.26 $)
- The stock's return over the last year (-26.26%) is lower than the sector average (-16.76%).
- Current debt level 52.16% has increased over 5 years from 32.77%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Baxter International | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.2% | -8.6% | -0.5% |
| 90 days | -22.3% | -11% | 8% |
| 1 year | -26.3% | -16.8% | 14.6% |
BAX vs Sector: Baxter International has significantly underperformed the "Healthcare" sector by -9.5% over the past year.
BAX vs Market: Baxter International has significantly underperformed the market by -40.9% over the past year.
Stable price: BAX is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BAX with weekly volatility of -0.505% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (23.98 $) is higher than the fair price (13.26 $).
Price is higher than fair: The current price (23.98 $) is 44.7% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (-18.84) is lower than that of the sector as a whole (29.26).
P/E vs Market: The company's P/E (-18.84) is lower than that of the market as a whole (52.32).
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.08) is lower than that of the sector as a whole (10.48).
P/BV vs Market: The company's P/BV (2.08) is lower than that of the market as a whole (18.5).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (1.37) is lower than that of the sector as a whole (3.99).
P/S vs Market: The company's P/S indicator (1.37) is lower than that of the market as a whole (27.95).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (23.55) is higher than that of the sector as a whole (18.36).
EV/Ebitda vs Market: The company's EV/Ebitda (23.55) is lower than that of the market as a whole (37.43).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -31.8% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-31.8%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.3%).
5.4. ROE
ROE vs Sector: The company's ROE (-8.45%) is higher than that of the sector as a whole (-73.65%).
ROE vs Market: The company's ROE (-8.45%) is lower than that of the market as a whole (36.05%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.4%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (-2.4%) is lower than that of the market as a whole (11.45%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (6.08%) is lower than that of the sector as a whole (21.56%).
ROIC vs Market: The company's ROIC (6.08%) is lower than that of the market as a whole (10.19%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 3.19% is higher than the average for the sector '1.3%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 3.19% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 3.19% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (22.06%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
